<?xml version="1.0" encoding="UTF-8"?>
<study api_version="0.6">
  <id>429</id>
  <name>3C and HiC of Plasmodium falciparum IT</name>
  <active>true</active>
  <user_id>29</user_id>
  <managers>
    <manager>
      <login>mjs</login>
      <email>mjs@sanger.ac.uk</email>
      <name>Mandy Sanders</name>
      <id>29</id>
    </manager>
  </managers>
  <owners>
    <owner>
      <login>mjs</login>
      <email>mjs@sanger.ac.uk</email>
      <name>Mandy Sanders</name>
      <id>29</id>
    </owner>
  </owners>
  <!-- Family has been deprecated -->
  <family_id></family_id>
  <created_at>2010-01-11 15:14:58 +0000</created_at>
  <updated_at>2011-05-03 16:23:09 +0100</updated_at>
  <descriptors>
    <descriptor>
      <name>SNP study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>What is the reason for preventing data release?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>ArrayExpress Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Please explain the reason for delaying release (e.g., pre-existing collaborative agreement)</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Alignments in BAM</name>
      <value>false</value>
    </descriptor>
    <descriptor>
      <name>Reason for delaying release</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding prevention of data release and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>How is the data release to be timed?</name>
      <value>standard</value>
    </descriptor>
    <descriptor>
      <name>Policy</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Study description</name>
      <value>Illumina sequencing of chromatin conformation capture and its derivatives is being carried out to study nuclear architecture in antigenically selected lines of Plasmodium falciparum. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/</value>
    </descriptor>
    <descriptor>
      <name>EGA Policy Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Will you be using WTSI's standard access agreement?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Study name abbreviation</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Does this study contain samples that are contaminated with human DNA which must be removed prior to analysis?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Study Visibility</name>
      <value>Hold</value>
    </descriptor>
    <descriptor>
      <name>Delay for</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>SNP parent study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding data release timing and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>EGA DAC Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has this been approved?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has the delay period been approved by the data sharing committee for this project?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>What is the data release strategy for this study?</name>
      <value>open</value>
    </descriptor>
    <descriptor>
      <name>Are all the samples to be used in this study commercially available, unlinked anonymised cell-lines?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Do any of the samples in this study contain human DNA?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>ENA Study Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Title</name>
      <value>Genome-Wide Subnuclear Architecture in Antigenically Selected Lines of P.falciparum </value>
    </descriptor>
    <descriptor>
      <name>Abstract</name>
      <value>We have used chromatin conformation capture and its derivatives to  study the nuclear architecture in lines of P.falciparum that express distinct variant antigens. Chemical crosslinking of cells followed by proximity based ligation and the subsequent enrichment of ligated junctions allows us  to estimate contact probabilities for all genomic loci at a resolution  of 10kB - 100kB. We evaluate these contact probabilities in the  context of polymer folding models to deduce the scaling principles and  folding architecture of interphase P. falciparum chromosomes. We  consider evidence for spatial segregation of subtelomeric chromosomal  territories involved in var gene expression as well as the anchoring  of heterochromatic regions to the nuclear periphery.</value>
    </descriptor>
    <descriptor>
      <name>ENA Project ID</name>
      <value>0</value>
    </descriptor>
    <descriptor>
      <name>Study Type</name>
      <value>Epigenetics</value>
    </descriptor>
    <descriptor>
      <name>Faculty Sponsor</name>
      <value>Matt Berriman</value>
    </descriptor>
    <descriptor>
      <name>What sort of study is this?</name>
      <value>transcriptomics</value>
    </descriptor>
    <descriptor>
      <name>Reference Genome</name>
      <value></value>
    </descriptor>
  </descriptors>
</study>
